Reuters logo
BRIEF-Catalyst Pharma drops in premarket after cocaine de-addiction drug trial results
November 8, 2012 / 1:42 PM / 5 years ago

BRIEF-Catalyst Pharma drops in premarket after cocaine de-addiction drug trial results

NEW YORK, Nov 8 (Reuters) - Catalyst Pharmaceutical Partners Inc : * Catalyst Pharma drops 66.2 percent to 49 cents in premarket after cocaine de-addiction drug trial results

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below